Background: Laparoscopic adrenalectomy is the gold standard for treatment of benign adrenal lesions. Tumor size is a factor that might influence decision-making concerning the use of laparoscopic approach. The aim of this study was to analyze the results of adrenalectomy for tumors ≥6 cm in diameter. Methods: Two groups of patients were analyzed: first group comprised 441 patients with tumors <6 cm in diameter and second group consisted of 89 patients with tumors ≥6 cm. Both groups were compared with regard to the duration of surgery, intraoperative blood loss, conversion and complications rate. Results: Median duration of surgery in groups 1 and 2 amounted to 86.6 and 111.9 min (p < 0.0001), respectively. Median intraoperative blood loss in groups 1 and 2 was 56.5 and 172.8 ml (p < 0.0001), respectively. There was a linear relationship between tumor size and the duration of surgery, and between tumor size and intraoperative blood loss (p < 0.0001). There were 2 (0.5%) and 6 (6.7%) conversions in groups 1 and 2, respectively. There were 41 (9.3%) and 14 (15.7%) complications in groups 1 and 2 (p = 0.0692), respectively. Conclusions: Laparoscopic adrenalectomy of tumors ≥6 cm is more difficult, but it can be regarded safe and beneficial for patients.

1.
Gagner M, Lacroix A, Bolté E: Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma. N Engl J Med 1992;327:1033.
2.
Brunt L: The positive impact of laparoscopic adrenalectomy on complications of adrenal surgery. Surg Endosc 2002;16:252-257.
3.
Hobart MG, Gill IS, Schweizer D, Sung GT, Bravo EL: Laparoscopic adrenalectomy for large-volume (> or = 5 cm) adrenal masses. J Endourol 2000;14:149-154.
4.
Lal G, Duh QY: Laparoscopic adrenalectomy- indications and technique. Surg Oncol 2003;12:105-123.
5.
Smith CD, Weber CJ, Amerson JR: Laparoscopic adrenalectomy: new gold standard. World J Surg 1999;23:389-396.
6.
Gumbs AA, Gagner M: Laparoscopic adrenalectomy. Best Pract Res Clin Endocrinol Metab 2006;20:483-499.
7.
Erbil Y, Barbaros U, Karaman G, Bozbora A, Ozarmağan S: The change in the principle of performing laparoscopic adrenalectomy from small to large masses. Int J Surg 2009;7:266-271.
8.
Major P, Pędziwiatr M, Matłok M, Ostachowski M, Winiarski M, Rembiasz K, et al: Cystic adrenal lesions - analysis of indications and results of treatment. Pol Przegl Chir 2012;84:184-189.
9.
Shi L, Cai W, Dong J, Zhang X, Gao J, Song T, et al: Single-port laparoscopic retroperitoneal surgery using a modified single-port device in urology. Urol Int 2014;92:83-88.
10.
Hu Q, Hang Z, Ho Y, Sun C, Xu K, Xia G, et al: Impact of obesity on perioperative outcomes of retroperitoneal laparoscopic adrenalectomy. Urol Int 2015;95:361-366.
11.
Naya Y, Suzuki H, Komiya A, Nagata M, Tobe T, Ueda T, et al: Laparoscopic adrenalectomy in patients with large adrenal tumors. Int J Urol 2005;12:134-139.
12.
Parnaby CN, Chong PS, Chisholm L, Farrow J, Connell JM, O'Dwyer PJ: The role of laparoscopic adrenalectomy for adrenal tumours of 6 cm or greater. Surg Endosc 2008;22:617-621.
13.
Barnett CC Jr, Varma DG, El-Naggar AK, Dackiw AP, Porter GA, Pearson AS, et al: Limitations of size as a criterion in the evaluation of adrenal tumors. Surgery 2000;128:973-982; discussion 982-983.
14.
Ramacciato G, Mercantini P, La Torre M, Di Benedetto F, Ercolani G, Ravaioli M, et al: Is laparoscopic adrenalectomy safe and effective for adrenal masses larger than 7 cm? Surg Endosc 2008;22:516-521.
15.
Zografos GN, Farfaras A, Vasiliadis G, Pappa T, Aggeli C, Vassilatou E, et al: Laparoscopic resection of large adrenal tumors. JSLS 2010;14:364-368.
16.
Agrusa A, Romano G, Frazzetta G, Chianetta D, Sorce V, Di Buono G, Gulotta G: Laparoscopic adrenalectomy for large adrenal masses: single team experience. Int J Surg 2014;12(suppl 1):S72-S74.
17.
Dalvi AN, Thapar PM, Thapar VB, Rege SA, Deshpande AA: Laparoscopic adrenalectomy for large tumours: single team experience. J Minim Access Surg 2012;8:125-128.
18.
Agha A, Iesalnieks I, Hornung M, Phillip W, Schreyer A, Jung M, et al: Laparoscopic trans- and retroperitoneal adrenal surgery for large tumors. J Minim Access Surg 2014;10:57-61.
19.
Boylu U, Oommen M, Lee BR, Thomas R: Laparoscopic adrenalectomy for large adrenal masses: pushing the envelope. J Endourol 2009;23:971-975.
20.
Fiszer P, Toutounchi S, Pogorzelski R, Krajewska E, Sutkowski B, Gierej P, Skórski M: Is tumour size a contraindication to laparoscopic adrenalectomy? Case report. Wideochir Inne Tech Maloinwazyjne 2012;7:144-146.
21.
Pędziwiatr M, Wierdak M, Ostachowski M, Natkaniec M, Białas M, Hubalewska-Dydejczyk A, Matłok M, Major P, Budzyński P, Migaczewski M, Budzyński A: Single center outcomes of laparoscopic transperitoneal lateral adrenalectomy - lessons learned after 500 cases: a retrospective cohort study. Int J Surg 2015;20:88-94.
22.
Gill IS: The case for laparoscopic adrenalectomy. J Urol 2001;166:429-436.
23.
Proye CA, Huart JY, Cuvillier XD, Assez NM, Gambardella B, Carnaille BM: Safety of the posterior approach in adrenal surgery: experience in 105 cases. Surgery 1993;114:1126-1131.
24.
Thompson GB, Grant CS, van Heerden JA, Schlinkert RT, Young WF Jr, Farley DR, Ilstrup DM: Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery 1997;122:1132-1136.
25.
Ishikawa T, Sowa M, Nagayama M, Nishiguchi Y, Yoshikawa K: Laparoscopic adrenalectomy: comparison with the conventional approach. Surg Laparosc Endosc 1997;7:275-280.
26.
Sturgeon C, Shen WT, Clark OH, Duh QY, Kebebew E: Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? J Am Coll Surg 2006;202:423-430.
27.
Sroka G, Slijper N, Shteinberg D, Mady H, Galili O, Matter I: Laparoscopic adrenalectomy for malignant lesions: surgical principles to improve oncologic outcomes. Surg Endosc 2013;27:2321-2326.
28.
Berruti A, Baudin E, Gelderblom H, Haak HR, Porpiglia F, Fassnacht M, et al: Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23(suppl 7):vii131-vii138.
29.
Stefanidis D, Goldfarb M, Kercher KW, Hope WW, Richardson W, Fanelli RD: SAGES guidelines for minimally invasive treatment of adrenal pathology. Surg Endosc 2013;27:3960-3980.
30.
Cooper AB, Habra MA, Grubbs EG, Bednarski BK, Ying AK, Perrier ND, Lee JE, Aloia TA: Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? Surg Endosc 2013;27:4026-4032.
31.
Miller BS, Gauger PG, Hammer GD, Doherty GM: Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy. Surgery 2012;152:1150-1157.
32.
Autorino R, Bove P, De Sio M, Miano R, Micali S, Cindolo L, Greco F, Nicholas J, Fiori C, Bianchi G, Kim FJ, Porpiglia F: Open versus laparoscopic adrenalectomy for adrenocortical carcinoma: a meta-analysis of surgical and oncological outcomes. Ann Surg Oncol 2015, Epub ahead of print.
33.
Zografos GN, Perysinakis I, Kyrodimou E, Kassi E, Kaltsas G: Surgical treatment of potentially primary malignant adrenal tumors: an unresolved issue. Hormones (Athens) 2015;14:47-58.
34.
Machado NO, Al Qadhi H, Al Wahaibi K, Rizvi SG: Laparoscopic adrenalectomy for large adrenocortical carcinoma. JSLS 2015;19:pii:e2015.00036.
35.
Henry JF, Peix JL, Kraimps JL: Positional statement of the European society of endocrine surgeons (ESES) on malignant adrenal tumors. Langenbecks Arch Surg 2012;397:145-146.
36.
Pędziwiatr M, Wierdak M, Natkaniec M, Matłok M, Białas M, Major P, Budzyński P, Hubalewska-Dydejczyk A, Budzyński A: Laparoscopic transperitoneal lateral adrenalectomy for malignant and potentially malignant adrenal tumours. BMC Surg 2015;28:101.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.